Abstract

SCOPE OF BRAHMI IN GROWTH AND DEVELOPMENT OF INFANTS

Srivastava Mayank*

Abstract

Introduction: A strong foundation for lifelong physical and mental health can be laid by maximizing the growth and development (G&D) of an infant, especially that of brain, because CNS plays a dominant role in unifying the whole organism as the infant develops and moves from one cycle of growth to next. In Ayurveda, Medhya dravyas are primarily indicated for improving the functions of brain, apart from having a myriad of other useful effects. Brahmi (Bacopa monnieri Linn) is one such drug widely recommended in Ayurveda for promoting G & D of children, but paucity exists regarding scientific studies supporting such a use in infancy. Aims and Objectives: To assess the effect of Brahmi on G & D of infants. Materials and Methods: Randomized controlled clinical trial was done on 34 newborns, divided into two groups- Group A (receiving Brahmi syrup orally twice daily in dose of 8 mg dry extract/kg/dose) and Group B (control group). Anthropometrical assessment of growth was done at monthly intervals, developmental assessment by Gesell developmental schedule (at 4, 16, 28 weeks) and the first appearance of social smile was noted, and the results were statistically analyzed. Results: Albeit the babies of both groups mostly demonstrated results ‘within normal limit; those of Group A often showed a general trend of having G & D on the earlier side of normal range. Conclusion: Ayurvedic Medhya drugs as Brahmi can play a promising role in maximizing the G&D within inherent genetic potential, and the early infantile period appears to be the best period for introducing them.

Keywords: Bacopa monnieri Linn, Brahmi, Brain, Growth and Development, Infants, Neonates.